Loo RK - Search Results

1

The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.

Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R Jr, Loo RK, Aaronson DS, Horwitz RI, Jacobsen SJ. Wallner LP, et al. Among authors: loo rk. Urology. 2018 Sep;119:70-78. doi: 10.1016/j.urology.2018.05.033. Epub 2018 Jun 12. Urology. 2018. PMID: 29906480 Free PMC article.

2

California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting.

Enger SM, Van den Eeden SK, Sternfeld B, Loo RK, Quesenberry CP Jr, Rowell S, Sadler MC, Schaffer DM, Habel LA, Caan BJ. Enger SM, et al. Among authors: loo rk. BMC Public Health. 2006 Jun 30;6:172. doi: 10.1186/1471-2458-6-172. BMC Public Health. 2006. PMID: 16813653 Free PMC article.

3

Association between 5-alpha reductase inhibition and risk of hip fracture.

Jacobsen SJ, Cheetham TC, Haque R, Shi JM, Loo RK. Jacobsen SJ, et al. Among authors: loo rk. JAMA. 2008 Oct 8;300(14):1660-4. doi: 10.1001/jama.300.14.1660. JAMA. 2008. PMID: 18840839

4

Correlates of prostate-specific antigen testing in a large multiethnic cohort.

Haque R, Van Den Eeden SK, Jacobsen SJ, Caan B, Avila CC, Slezak J, Sternfeld B, Loo RK, Quinn VP. Haque R, et al. Among authors: loo rk. Am J Manag Care. 2009 Nov;15(11):793-9. Am J Manag Care. 2009. PMID: 19895183 Free article.

5

Early development of castrate resistance varies with different dosing regimens of luteinizing hormone releasing hormone agonist in primary hormonal therapy for prostate cancer.

Blumberg JM, Kwon EO, Cheetham TC, Niu F, Shapiro CE, Pacificar J, Loo RK, Williams SG, Chien GW. Blumberg JM, et al. Among authors: loo rk. Urology. 2011 Feb;77(2):412-6. doi: 10.1016/j.urology.2010.08.037. Epub 2010 Dec 15. Urology. 2011. PMID: 21111460

6

Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction.

Gleason JM, Slezak JM, Jung H, Reynolds K, Van den Eeden SK, Haque R, Quinn VP, Loo RK, Jacobsen SJ. Gleason JM, et al. Among authors: loo rk. J Urol. 2011 Apr;185(4):1388-93. doi: 10.1016/j.juro.2010.11.092. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334642

7

Association of hematuria on microscopic urinalysis and risk of urinary tract cancer.

Jung H, Gleason JM, Loo RK, Patel HS, Slezak JM, Jacobsen SJ. Jung H, et al. Among authors: loo rk. J Urol. 2011 May;185(5):1698-703. doi: 10.1016/j.juro.2010.12.093. Epub 2011 Mar 21. J Urol. 2011. PMID: 21419446

8

Contribution of common medications to lower urinary tract symptoms in men.

Wuerstle MC, Van Den Eeden SK, Poon KT, Quinn VP, Hollingsworth JM, Loo RK, Jacobsen SJ; Urologic Diseases in America Project. Wuerstle MC, et al. Among authors: loo rk. Arch Intern Med. 2011 Oct 10;171(18):1680-2. doi: 10.1001/archinternmed.2011.475. Arch Intern Med. 2011. PMID: 21987200 Free PMC article. No abstract available.

9

Population-based study of erectile dysfunction and polypharmacy.

Londoño DC, Slezak JM, Quinn VP, Van Den Eeden SK, Loo RK, Jacobsen SJ. Londoño DC, et al. Among authors: loo rk. BJU Int. 2012 Jul;110(2):254-9. doi: 10.1111/j.1464-410X.2011.10761.x. Epub 2011 Nov 15. BJU Int. 2012. PMID: 22085284

10

Prostate cancer screening trends in a large, integrated health care system.

Wallner L, Frencher S, Hsu JW, Loo R, Huang J, Nichol M, Jacobsen S. Wallner L, et al. Perm J. 2012 Summer;16(3):4-9. doi: 10.7812/TPP/12.969. Perm J. 2012. PMID: 23012592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters